1

Advanced cGMP Facility for Cell & Gene Therapy Manufacturing in Hong Kong

News Discuss 
Xellera Therapeutics operates Hong Kong’s first multi-product cGMP facility, featuring Grade A/B cleanrooms and fully integrated QC, process development, and R&D laboratories. Built for flexibility and scalability, the site supports clinical to commercial manufacturing in compliance with US FDA, EMA, PIC/S, and HK DoH guidelines. https://www.xelleratherapeutics.com/facilities/

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story